Stephanie Neuhaus
Pediatrics · Omaha, NENPI 1497850697
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $433 and has fallen 96.3% since, to $16 in 2025.
Across 119 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$250
- Amgen$246
- Johnson & Johnson$158
- Takeda Pharmaceuticals U.S.A., Inc.$135
- Otsuka America Pharmaceutical, Inc.$114
- Tris Pharma Inc$81
- plus $700 from 23 others
What the payments were for
- Food & beverage$1,683100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $250 |
| Amgen | 19 | $246 |
| Johnson & Johnson | 11 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $135 |
| Otsuka America Pharmaceutical, Inc. | 7 | $114 |
| Tris Pharma Inc | 5 | $81 |
| AstraZeneca | 6 | $80 |
| Pfizer | 6 | $79 |
| Amarin Pharma, Inc. | 4 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $61 |
| Lilly USA, LLC | 4 | $54 |
| Boston Scientific | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Nalpropion Pharmaceuticals LLC | 2 | $27 |
| Bayer | 2 | $27 |
| Boehringer Ingelheim | 2 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| Sobi, Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,683 in reported general payments places this provider in the 85th percentile of 308 pediatrics providers in Nebraska.
Other pediatrics in Omaha
- Sachit PatelOmaha$91K
- Rachel AndersonOmaha$76K
- Amy LacroixOmaha$40K
- Hana NieburOmaha$25K
- Melissa Muff-LuettOmaha$16K
- Karl RothOmaha$12K
- Danita VelascoOmaha$11K
- Rachel TaylorOmaha$10K
- Philip BoucherOmaha$10K
- Bernard DouglasOmaha$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.